BIOMARIN PHARMACEUTICAL INC - COM (BMRN)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
182 M
Holdings value Q1 2024
$15.9 B
Value change Q1 2024
-$282 M
Grand Portfolio weight change Q1 2024
-0.001%
Number of holders
526
Number of buys Q1 2024
240
Number of sells Q1 2024
-243
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.004%
CUSIP
09061G101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 16.2 K $1.33 M -$15.9 K $82.33 4
2024 Q1 183 M $16 B -$282 M $87.34 530
2023 Q4 185 M $17.8 B +$760 M $96.42 524
2023 Q3 177 M $15.7 B +$285 M $88.48 506
2023 Q2 174 M $15 B -$352 M $86.68 540
2023 Q1 178 M $17.3 B -$368 M $97.24 539
2022 Q4 182 M $18.8 B +$34 M $103.49 565
2022 Q3 181 M $15.4 B +$268 M $84.77 529
2022 Q2 178 M $14.7 B +$135 M $82.87 514
2022 Q1 176 M $13.6 B +$44.9 M $77.10 531
2021 Q4 176 M $15.5 B +$127 M $88.35 539
2021 Q3 175 M $13.5 B +$30.9 M $77.29 493
2021 Q2 174 M $14.5 B -$128 M $83.44 502
2021 Q1 175 M $13.2 B -$346 M $75.51 507
2020 Q4 179 M $15.7 B +$287 M $87.69 523
2020 Q3 179 M $13.6 B -$306 M $76.08 479
2020 Q2 180 M $22.2 B +$740 M $123.34 520
2020 Q1 176 M $14.9 B +$294 M $84.50 477
2019 Q4 173 M $14.6 B +$51 M $84.55 450
2019 Q3 173 M $11.7 B -$330 M $67.40 426
2019 Q2 177 M $15.2 B +$224 M $85.65 467
2019 Q1 178 M $15.8 B -$82.1 M $88.83 474
2018 Q4 179 M $15.2 B -$188 M $85.15 463
2018 Q3 181 M $17.5 B -$163 M $96.97 450
2018 Q2 183 M $17.2 B +$243 M $94.20 439
2018 Q1 180 M $14.6 B +$187 M $81.07 421
2017 Q4 178 M $15.8 B +$219 M $89.17 430
2017 Q3 175 M $16.2 B +$376 M $93.07 407
2017 Q2 169 M $15.3 B +$218 M $90.82 419
2017 Q1 169 M $14.8 B +$900 M $87.78 412
2016 Q4 169 M $14 B +$54.3 M $82.84 408
2016 Q3 168 M $15.6 B +$821 M $92.52 420
2016 Q2 160 M $12.4 B -$242 M $77.80 391
2016 Q1 163 M $13.4 B +$69.8 M $82.48 381
2015 Q4 166 M $16.9 B +$172 M $104.76 384
2015 Q3 159 M $16.8 B +$118 M $105.32 390
2015 Q2 157 M $21.4 B +$130 M $136.78 390
2015 Q1 157 M $19.5 B +$1.29 B $124.62 379
2014 Q4 148 M $13.3 B +$131 M $90.40 338
2014 Q3 148 M $10.7 B +$238 M $72.16 313
2014 Q2 145 M $8.99 B -$275 M $62.21 321
2014 Q1 147 M $10.1 B +$473 M $68.21 309